SCHEMBL29601639

SCHEMBL29601639

N#Cc1ccc(OCC(F)(F)F)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.40
NSD2 O96028 1/20 0.39
NSD3 Q9BZ95 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
DGAT1 O75907 1/20 0.37
CHEK1 O14757 6/20 0.37
CACNA1G O43497 2/20 0.37
CACNA1H O95180 2/20 0.37
CACNA1I Q9P0X4 2/20 0.37
CNR2 P34972 1/20 0.37
KCNH2 Q12809 1/20 0.37
GPR3 P46089 1/20 0.36
SCN5A Q14524 1/20 0.36
CYP17A1 P05093 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17395028 1.00 TRPA1 (0.40) TRPA1NSD2NSD3ALDH1A1MAPT
SCHEMBL17992210 0.86 TRPA1 (0.39) TRPA1NSD2NSD3DGAT1CHEK1
SCHEMBL19767081 0.86 AR (0.39) TRPA1NSD2NSD3DGAT1CHEK1
SCHEMBL17992321 0.83 HTT (0.41) TRPA1NSD2NSD3ALDH1A1MAPT
SCHEMBL29620884 0.78 TRPA1 (0.55) TRPA1ALDH1A1MAPTDGAT1KCNH2
SCHEMBL10329121 0.78 TRPA1 (0.55) TRPA1ALDH1A1MAPTDGAT1KCNH2
SCHEMBL22120385 0.77 NSD2 (0.49) NSD2NSD3ALDH1A1CHEK1L3MBTL1
SCHEMBL2323409 0.77 MAOB (0.48) ALDH1A1MAPTGPR3SCN5AKDM4E
SCHEMBL795973 0.77 ALDH1A1 (0.43) TRPA1ALDH1A1DGAT1CHEK1
SCHEMBL27001727 0.76 NSD2 (0.46) NSD2NSD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed